BioCentury | Jan 23, 2012
Company News

Hikma Pharmaceuticals, Societe de Promotion deal

...see BioCentury, Oct. 10, 2011 & Dec. 12, 2011). Hikma Pharmaceuticals plc (LSE:HIK), London, U.K. Societe de Promotion Pharmaceutique du Maghreb S.A....
BioCentury | Dec 12, 2011
Company News

Hikma Pharmaceuticals, Societe de Promotion deal

...the company for $111.2 million (see BioCentury, Oct. 10). Hikma Pharmaceuticals plc (LSE:HIK), London, U.K. Societe de Promotion Pharmaceutique du Maghreb S.A....
BioCentury | Oct 10, 2011
Company News

Hikma Pharmaceuticals, Societe de Promotion Pharmaceutique du Maghreb S.A. deal

...remaining 36.1%. Hikma expects to complete the tender offer by the end of the year. Societe de Promotion...
...be accretive in 2012, with a seven-year syndicated loan. Hikma Pharmaceuticals plc (LSE:HIK), London, U.K. Societe de Promotion Pharmaceutique du Maghreb S.A....
Items per page:
1 - 3 of 3
BioCentury | Jan 23, 2012
Company News

Hikma Pharmaceuticals, Societe de Promotion deal

...see BioCentury, Oct. 10, 2011 & Dec. 12, 2011). Hikma Pharmaceuticals plc (LSE:HIK), London, U.K. Societe de Promotion Pharmaceutique du Maghreb S.A....
BioCentury | Dec 12, 2011
Company News

Hikma Pharmaceuticals, Societe de Promotion deal

...the company for $111.2 million (see BioCentury, Oct. 10). Hikma Pharmaceuticals plc (LSE:HIK), London, U.K. Societe de Promotion Pharmaceutique du Maghreb S.A....
BioCentury | Oct 10, 2011
Company News

Hikma Pharmaceuticals, Societe de Promotion Pharmaceutique du Maghreb S.A. deal

...remaining 36.1%. Hikma expects to complete the tender offer by the end of the year. Societe de Promotion...
...be accretive in 2012, with a seven-year syndicated loan. Hikma Pharmaceuticals plc (LSE:HIK), London, U.K. Societe de Promotion Pharmaceutique du Maghreb S.A....
Items per page:
1 - 3 of 3